Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer | PLOS ONE
![OWise on Twitter: "🔍Do you know what the blood markers CA 15-3, CA 27-29 and CEA are? Blood tests🩸measure the levels of these proteins in breast cancer patients. Read below to find OWise on Twitter: "🔍Do you know what the blood markers CA 15-3, CA 27-29 and CEA are? Blood tests🩸measure the levels of these proteins in breast cancer patients. Read below to find](https://pbs.twimg.com/media/E2OlO4SXEAIVjza.jpg:large)
OWise on Twitter: "🔍Do you know what the blood markers CA 15-3, CA 27-29 and CEA are? Blood tests🩸measure the levels of these proteins in breast cancer patients. Read below to find
![Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase | British Journal of Cancer Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase | British Journal of Cancer](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fbjc.2015.8/MediaObjects/41416_2015_Article_BFbjc20158_Fig1_HTML.jpg)
Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase | British Journal of Cancer
Elevated Levels of Serum Tumor Markers CEA and CA15-3 Are Prognostic Parameters for Different Molecular Subtypes of Breast Cancer | PLOS ONE
![IJMS | Free Full-Text | Nipple Discharge of CA15-3, CA125, CEA and TSGF as a New Biomarker Panel for Breast Cancer IJMS | Free Full-Text | Nipple Discharge of CA15-3, CA125, CEA and TSGF as a New Biomarker Panel for Breast Cancer](https://www.mdpi.com/ijms/ijms-15-09546/article_deploy/html/images/ijms-15-09546-g001.png)
IJMS | Free Full-Text | Nipple Discharge of CA15-3, CA125, CEA and TSGF as a New Biomarker Panel for Breast Cancer
![Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-020-75319-8/MediaObjects/41598_2020_75319_Fig1_HTML.png)
Limited usefulness of serum carcinoembryonic antigen and carbohydrate antigen 19-9 levels for gastrointestinal and whole-body cancer screening | Scientific Reports
![Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs12282-020-01058-3/MediaObjects/12282_2020_1058_Fig3_HTML.png)
Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study | SpringerLink
![CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41416-021-01431-9/MediaObjects/41416_2021_1431_Fig1_HTML.png)
CEA, CA19-9, circulating DNA and circulating tumour cell kinetics in patients treated for metastatic colorectal cancer (mCRC) | British Journal of Cancer
![Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect Clinical utility of tumour marker velocity of cancer antigen 15–3 (CA 15–3) and carcinoembryonic antigen (CEA) in breast cancer surveillance - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0960977620301120-fx1.jpg)